Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Techniclone restructures TNT development joint venture

May 29, 1998

Ribozyme and Roche Bioscience enter ribozyme-based research collaboration

May 27, 1998

Patent covering MEKK-related assays licensed to Cadus

May 26, 1998

New tool identified for exploring the adenosine A3 receptor

May 25, 1998

Cell Genesys granted patent covering AAV vector technology

May 25, 1998

Therapeutic Antibodies and Searle announce research collaboration

May 25, 1998

Ribozyme progresses in target validation collaboration with Schering AG

May 25, 1998

Fuisz's EA technology improves onset of action of pain drugs

May 22, 1998

New P2Y1 antagonist will facilitate further study of the receptor and its physiological role

May 21, 1998

Lilly initiates pivotal trials with SkyePharma formulation

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...